Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
23:37:28 02/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+17.09% | +10.91% |
| Market Cap | 21.01M 18.89M 17.63M 15.98M 30M 2B 30.19M 212M 82.62M 1.04B 78.89M 77.19M 3.34B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 23.74M 21.35M 19.92M 18.05M 33.9M 2.26B 34.11M 239M 93.35M 1.17B 89.13M 87.2M 3.77B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +17.09% | ||
| Current month | +8.58% | ||
| 1 month | +10.91% | ||
| 3 months | -0.32% | ||
| 6 months | +12.93% | ||
| Current year | +10.91% |
| 1 week | 0.05 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/10/26 | Exercice | Chief Executive Officer | -22,609 | 0.0054% | ||
| 03/10/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 18/09/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | +17.09% | -18.38% | -11.43% | 21.01M | |
| -2.01% | -7.86% | +60.74% | +70.97% | 68.92B | |
| +0.19% | +5.95% | +6.56% | +59.06% | 51.9B | |
| +2.51% | +6.60% | +11.89% | +40.95% | 48.73B | |
| +0.51% | +1.51% | +27.96% | +31.43% | 43.13B | |
| +2.70% | -3.66% | +307.41% | +547.01% | 41.48B | |
| +0.69% | -3.44% | +9.52% | +96.59% | 39.96B | |
| +0.06% | -2.02% | +11.25% | +43.27% | 30.6B | |
| -2.21% | -10.09% | +35.34% | -0.73% | 26.01B | |
| -0.39% | -6.92% | -13.60% | -14.40% | 22.27B | |
| Average | -0.52% | -4.12% | +43.87% | +86.27% | 37.3B | |
| Weighted average by Cap. | +0.25% | -4.28% | +54.70% | +104.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.52 0.47 0.88 58.73 0.89 6.21 2.43 30.48 2.32 2.27 98.03 | 0.34 0.3 0.28 0.26 0.48 31.99 0.48 3.38 1.32 16.6 1.26 1.23 53.39 |
| Net income | -4.76M -4.28M -4M -3.62M -6.8M -453M -6.84M -47.95M -18.72M -235M -17.88M -17.49M -756M | -5.43M -4.88M -4.56M -4.13M -7.75M -517M -7.8M -54.69M -21.35M -268M -20.39M -19.95M -863M |
| Net Debt | 2.88M 2.59M 2.41M 2.19M 4.11M 274M 4.13M 28.97M 11.31M 142M 10.8M 10.57M 457M | 2.73M 2.45M 2.29M 2.07M 3.89M 260M 3.92M 27.46M 10.72M 135M 10.24M 10.02M 433M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/10/26 | $0.0500 | -9.09% | 114,492 |
| 13/10/26 | $0.0550 | +2.04% | 14,200 |
| 12/10/26 | $0.0539 | +1.89% | 6,697 |
| 09/10/26 | $0.0529 | +5.80% | 30,409 |
| 08/10/26 | $0.0500 | -5.57% | 105,005 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
